About GLP-3 Wiki
GLP-3 Wiki is an independent, research-backed reference on retatrutide — Eli Lilly’s investigational triple agonist for obesity and type 2 diabetes — and the broader GLP-1 class of weight loss drugs.
We are not affiliated with Eli Lilly, Novo Nordisk, or any pharmaceutical company. Nothing on this site is medical advice. Every article is grounded in published clinical trial data, regulatory filings, or peer-reviewed literature — sourced and linked directly wherever possible.
Read the methodology for how sources, study limitations and updates are handled, and the disclaimer for the limits of this reference.
Feedback, corrections and sponsorship
Send a correction, suggest an improvement or ask about sponsorship. You can also email glp3@jkyf.dev.